Brazilian red propolis extract free and encapsulated into polymeric nanoparticles against ovarian cancer: formulation, characterisation and biological assays in 2D and 3D models
- 13 April 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 75 (6) , 806-818
Abstract
Cancer incidence worldwide is alarming and among the cancers that affect women ovarian cancer is the most fatal. Many side effects are associated with conventional therapies and none of them are completely effective, so the development of new treatments is necessary. Brazilian red propolis extract is a natural product with complex composition and great potential for cancer treatment. However, its clinical application is harmed due to unfavourable physicochemical characteristics. To enable its application encapsulation in nanoparticles can be used. Objectives: The aims of this work were to develop polymeric nanoparticles with Brazilian red propolis extract and compare their action with the free extract against ovarian cancer cells. Methods: Box Behnken design was used and nanoparticles were characterised using the techniques dynamic light scattering, nanoparticle tracking analysis, transmission electron microscopy, differential scanning calorimetry and encapsulation efficiency. Activity against OVCAR-3 was also tested on 2D and 3D models. Key findings: Nanoparticles’ sizes were ~200 nm with monomodal size distribution, negative zeta potential, spherical shape and with extract molecularly dispersed. Encapsulation efficiency was above 97% for the biomarkers chosen. Nanoparticles had greater efficacy in comparison with free propolis in OVCAR-3. Conclusions: So far, the nanoparticles here described have the potential to be a chemotherapy treatment in the future.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2018/13465-5)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2017/04138-8)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2016/16921-6)
- National Institute of Science and Technology in Pharmaceutical Nanotechnology (#2014/50928)
- INCT-Nanofarma
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (#465687/2014-8)
This publication has 49 references indexed in Scilit:
- Nanoparticles containing insoluble drug for cancer therapyBiotechnology Advances, 2014
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- Box–Behnken design based statistical modeling for ultrasound-assisted extraction of corn silk polysaccharideCarbohydrate Polymers, 2013
- Formulation of lipid core nanocapsulesColloids and Surfaces A: Physicochemical and Engineering Aspects, 2011
- Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic DisseminationCancer Research, 2009
- Neutral red uptake assay for the estimation of cell viability/cytotoxicityNature Protocols, 2008
- Box-Behnken design: An alternative for the optimization of analytical methodsAnalytica Chimica Acta, 2007
- An Overview of Polylactides as Packaging MaterialsMacromolecular Bioscience, 2004
- The influence of lipid nanocapsule composition on their size distributionEuropean Journal of Pharmaceutical Sciences, 2003
- Effects of physical aging on glass transition behavior of poly(dl-lactide)European Polymer Journal, 2002